2020
DOI: 10.1021/acs.oprd.0c00367
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Nonprecious Metal Catalysis

Abstract: This highlight is the second installment of a series of highlights on nonprecious-metal-catalyzed reactions of interest to the pharmaceutical industry. Selected transformations from March to June 2020 are summarized. Our goal is to facilitate advancements in the areas of safer and greener chemical manufacturing using earth-abundant metals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 97 publications
0
14
0
Order By: Relevance
“…Studies by several research groups, including those of MacMillan, Weix, Reisman, Gong, and others, have established the feasibility and synthetic effectiveness of this chemistry, as highlighted earlier in this review series. 3,4 MacMillan described the use of silanemediated bromine atom abstraction under dual nickel/photoredox catalysis as an alternative approach for the crosselectrophile coupling of aryl bromides and alkyl bromides. 22 Recently, MacMillan's group communicated 23 the modification of the silane substituents to amplify the electron density on an open-shell silicon group, resulting in an increased polarity that is properly tuned for the matching effect between an unactivated C−Cl bond and the silyl abstraction reagent (Scheme 11).…”
Section: ■ Recent Reports On Ni-catalyzed Reactionsmentioning
confidence: 99%
See 2 more Smart Citations
“…Studies by several research groups, including those of MacMillan, Weix, Reisman, Gong, and others, have established the feasibility and synthetic effectiveness of this chemistry, as highlighted earlier in this review series. 3,4 MacMillan described the use of silanemediated bromine atom abstraction under dual nickel/photoredox catalysis as an alternative approach for the crosselectrophile coupling of aryl bromides and alkyl bromides. 22 Recently, MacMillan's group communicated 23 the modification of the silane substituents to amplify the electron density on an open-shell silicon group, resulting in an increased polarity that is properly tuned for the matching effect between an unactivated C−Cl bond and the silyl abstraction reagent (Scheme 11).…”
Section: ■ Recent Reports On Ni-catalyzed Reactionsmentioning
confidence: 99%
“…As part of the engagement of the Boehringer Ingelheim (BI) process chemistry group in a precompetitive space with AbbVie and Pfizer process chemists in an attempt to promote the development and applications of NPMC, a series of review articles has been initiated to highlight recent advancements in the field. The first review was authored by a team of process chemists at Pfizer and the second by a team of process chemists at AbbVie . This review is the third installment of the series and covers articles in the field of NPMC published between July and October 2020.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Over the past couple decades, the use of transition-metal-catalyzed cross-coupling reactions have become a staple within the organic chemist's arsenal of carbon-carbon and carbon-heteroatom bond-forming reactions. Catalysis, as a synthetic tool, is widely employed to accomplish transformations to produce many various pharmaceuticals, polymeric materials, and fine chemicals [1][2][3][4][5][6][7][8]. Catalysis is one of the fundamental pillars of green chemistry, the design of chemical products and processes that reduce or eliminate the use and generation of hazardous substances, as well as increase the atom economy of the reac-tion [9].…”
Section: Introductionmentioning
confidence: 99%
“…Here we continue a review series initiated by a precompetitive process chemistry alliance at AbbVie, Pfizer, and Boehringer Ingelheim that highlights recent reports of nonprecious metal catalysis of interest to the pharmaceutical process development community. This review covers articles published from March through June 2021. The nonprecious metal catalysts covered in this review include examples with Ni, Cu, Fe, Mn, Co, Ti, Mg, Zn, and K.…”
mentioning
confidence: 99%